Cardinal Health, Inc. $CAH Shares Purchased by Three Seasons Wealth LLC

Three Seasons Wealth LLC lifted its stake in Cardinal Health, Inc. (NYSE:CAH) by 160.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,466 shares of the company’s stock after purchasing an additional 2,750 shares during the quarter. Three Seasons Wealth LLC’s holdings in Cardinal Health were worth $944,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Norges Bank purchased a new position in shares of Cardinal Health in the fourth quarter worth $790,344,000. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares during the period. Marshall Wace LLP grew its holdings in shares of Cardinal Health by 1,328.1% during the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock valued at $195,484,000 after buying an additional 884,648 shares during the last quarter. SG Americas Securities LLC increased its position in shares of Cardinal Health by 3,829.1% in the 4th quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock valued at $149,504,000 after acquiring an additional 708,995 shares during the period. Finally, Vanguard Group Inc. increased its position in shares of Cardinal Health by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after acquiring an additional 617,775 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 2.3%

Cardinal Health stock opened at $224.75 on Thursday. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $243.21. The stock’s 50 day simple moving average is $214.48 and its two-hundred day simple moving average is $213.51. The firm has a market cap of $52.64 billion, a PE ratio of 34.37, a P/E/G ratio of 1.13 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same period in the previous year, the firm earned $2.35 EPS. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts forecast that Cardinal Health, Inc. will post 10.77 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were given a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date was Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is 31.50%.

Analysts Set New Price Targets

A number of analysts have commented on CAH shares. JPMorgan Chase & Co. lowered their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research report on Monday, May 4th. Weiss Ratings lowered Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. Morgan Stanley raised their price objective on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. TD Cowen lifted their target price on Cardinal Health from $255.00 to $275.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Finally, Wells Fargo & Company dropped their target price on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $249.13.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.